AAOMS Annual Meeting

Conference Coverage

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

Diabetes Q&A
Diabetes Q&A
Newly Approved Continuous Glucose Monitoring System Does Not Require Fingerstick
09/28/2017
The US Food and Drug Administration has approved a new continuous glucose monitoring system for adult patients with diabetes.
09/28/2017
Oncology
Oncology
FDA Expands Nivolumab Approval for Type of Liver Cancer
09/25/2017
The US Food and Drug Administration (FDA) has indicated nivolumab for intravenous use in patients with previously treated liver cancer.
09/25/2017
Oncology
Oncology
FDA Expands Nivolumab Approval for Type of Liver Cancer
09/25/2017
The US Food and Drug Administration (FDA) has indicated nivolumab for intravenous use in patients with previously treated liver cancer.
09/25/2017
Oncology
Oncology
FDA Expands Nivolumab Approval for Type of Liver Cancer
09/25/2017
The US Food and Drug Administration (FDA) has indicated nivolumab for intravenous use in patients with previously treated liver cancer.
09/25/2017
Oncology
Oncology
FDA Approval Alert: Expanded Indication for Gastric Cancer Therapy
09/25/2017
The US Food and Drug Administration (FDA) expanded the approval of a targeted therapy to treat gastric or gastroesophageal junction (GEJ) cancer.
09/25/2017
COPD
COPD
FDA Approves First 3-in-1 Inhaler for COPD
09/19/2017
The US Food and Drug Administration recently approved the first single dose once-daily inhaler to be used as maintenance therapy for patients with chronic obstructive pulmonary disease.
09/19/2017
COPD
COPD
FDA Approves First 3-in-1 Inhaler for COPD
09/19/2017
The US Food and Drug Administration recently approved the first single dose once-daily inhaler to be used as maintenance therapy for patients with chronic obstructive pulmonary disease.
09/19/2017
COPD
COPD
FDA Approves First 3-in-1 Inhaler for COPD
09/19/2017
The US Food and Drug Administration recently approved the first single dose once-daily inhaler to be used as maintenance therapy for patients with chronic obstructive pulmonary disease.
09/19/2017
FDA
FDA
FDA: First Single-Dose Treatment for Bacterial Vaginosis
09/18/2017
The US Food and Drug Administration has approved a new option for the treatment of bacterial vaginosis in adult women.
09/18/2017
FDA
FDA
FDA: First Single-Dose Treatment for Bacterial Vaginosis
09/18/2017
The US Food and Drug Administration has approved a new option for the treatment of bacterial vaginosis in adult women.
09/18/2017